Clinical Trials Browser

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Completed

24 enrolled

GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

NCT06749600 2025-06-18

POLMS

Recruiting

30 enrolled

Sarcoma

Neoplasms, Neoplasms by Histologic Type, Neoplasms, Muscle Tissue, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Phase NA Enrolling by invitation

300 enrolled

Sarcoma

Sarcoma, Risk Reduction Behavior

NCT03670927 2024-11-07

Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

Phase NA Unknown

31 enrolled

Sarcoma

NCT05827458 2023-04-25

TOSS

Completed

500 enrolled

Sarcoma

Bone Neoplasms, Neoplasms, Sarcoma, Soft Tissue Neoplasms

NCT05747521 2023-02-28

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

Phase NA Unknown

85 enrolled

Sarcoma

NCT04223583 2022-03-16

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

Phase 4 Completed

70 enrolled

Sarcoma

NCT04158414 2019-11-08

Applying PET/MR in Oncology - a Prospective Project

Phase NA Unknown

500 enrolled

GastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcoma

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lymphoma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Phase 2 Unknown

60 enrolled

GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

35 enrolled

Sarcoma

Recurrence, Sarcoma

NCT00687778 2008-06-02

11C-Acetate PET/CT Non-FDG-Avid Tumors

Unknown

100 enrolled

EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Carcinoma, Hepatocellular, Lung Neoplasms, Sarcoma, Teratoma, Thyroid Neoplasms, Carcinoma, Lobular, Neuroendocrine Tumors

Clinical Trials

MULTISARC

MULTIPLI-0

POLMS

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

ETIOSARC

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Study on Clinical Features, Treatment Mode and Survival of Sarcoma

Cryoablation for Advanced Bone and Soft Tissue Tumors

Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

TOSS

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

Applying PET/MR in Oncology - a Prospective Project

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

11C-Acetate PET/CT Non-FDG-Avid Tumors